|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 143.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 409.00 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.000001 mmHg @ 25.00 °C. (est) |
| Flash Point: | 248.00 °F. TCC ( 120.10 °C. ) (est)
|
| logP (o/w): | 4.962 (est) |
| Soluble in: |
| | water, 1.068 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intravenous-cat LDLo 33 mg/kg Compilation of LD50 Values of New Drugs.
oral-human TDLo 100 ug/kg BEHAVIORAL: TOXIC PSYCHOSIS Proceedings of the European Society for the Study of Drug Toxicity. Vol. 8, Pg. 59, 1967.
intraperitoneal-mouse LD50 65 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION Archives Internationales de Pharmacodynamie et de Therapie. Vol. 144, Pg. 555, 1963.
intravenous-mouse LD50 24 mg/kg "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 208, 1972.
oral-mouse LD50 91 mg/kg Drugs in Japan Vol. 6, Pg. 775, 1982.
oral-rat LD50 940 mg/kg Drugs in Japan Vol. 6, Pg. 775, 1982.
|
| Dermal Toxicity: |
subcutaneous-guinea pig LD50 80 mg/kg AUTONOMIC NERVOUS SYSTEM: PARASYMPATHOLYTIC Archives Internationales de Pharmacodynamie et de Therapie. Vol. 137, Pg. 375, 1962.
subcutaneous-mouse LD50 103 mg/kg "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 208, 1972.
subcutaneous-rat LD50 353 mg/kg "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 208, 1972.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for benztropine mesylate usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for benztropine mesylate flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
| | (1R,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane;methanesulfonicacid |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 8584 |
| Pubchem (sid): | 134973916 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether methanesulfonate | | (1R,5R)-3- | benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane;methanesulfonicacid | | | benzotropine methanesulfonate | | | benzotropinemesylate | | | benztropine mesilate | | | benztropine methanesulfonate | | 8-aza | bicyclo(3.2.1)octane, 3-(diphenylmethoxy)-, endo-, methanesulfonate | | 8-aza | bicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-, methanesulfonate (9CI) | | | cobrentin methanesulfonate | | | cogentin | | | cogentin methanesulfonate | | 3- | diphenyl methoxytropane methanesulfonate | | endo-3-( | diphenylmethoxy)-8-methyl-8-azoniabicyclo(3.2.1)octane methanesulphonate | | 3- | diphenylmethoxytropane mesylate | | 3- | diphenylmethoxytropane methanesulfonate | | | lopac-B-8262 | | N- | methylbenztropine | | | tropine benzohydryl ether methanesulfonate |
Articles:
|